Betadine Solution
FDA Label NDC 67618-153

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Atlantis Consumer Healthcare, Inc. for the product Betadine (NDC 67618-153). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding drug facts, purpose, uses, warnings, do not use this product, when using this product, stop using this product, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Drug Facts

Active Ingredient Purpose

Povidone-iodine Solution USP, 10% (equal to 1% available iodine)

Purpose

Antiseptic

Uses

  • for preparation of the skin prior to surgery
  • helps reduce bacteria that can potentially cause skin infection

Warnings

For external use only

Do Not Use This Product

  • in the eyes
  • if you are allergic to iodine or other product ingredients

When Using This Product

  • prolonged exposure may cause irritation or, rarely, severe skin reactions

Stop Using This Product

  • in rare instances of local irritation or sensitivity
  • if irritation and redness develop and continue for more than 72 hours

Directions

  • tear at slit; pull top of packette across, exposing end of swabstick
  • remove Betadine Solution Swabstick and apply as needed
  • use one time only

Other Information

  • store between 20°-25°C (68°-77°F)
  • Avoid freezing and excessive heat above 40°C (104°F)

Inactive Ingredients

citric acid, disodium phosphate, nonoxynol-9, purified water, sodium hydroxide

* Please review the disclaimer below.